Systematic identification of pathological lamin A interactors

Molecular Biology of the Cell

Volumn 25, Issue 9, 2014, Pages 1493-1510

  Dittmer, Travis A ^a   Sahni, Nidhi ^b,c   Kubben, Nard ^a   Hill, David E ^b,c   Vidal, Marc ^b,c   Burgess, Rebecca C ^a   Roukos, Vassilis ^a   Misteli, Tom ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; IMMUNOGLOBULIN G; LAMIN A; LAMIN A BINDING PROTEIN; LAMIN C; LAMIN C BINDING PROTEIN; UNCLASSIFIED DRUG; LMNA PROTEIN, HUMAN; PROTEIN BINDING;

ARTICLE; CARDIOMYOPATHY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOTOXICITY; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; LAMINOPATHY; MUSCULAR DYSTROPHY; NONHUMAN; PATHOGENESIS; PREMATURE AGING; PRIORITY JOURNAL; PROGERIA; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN STRUCTURE; SACCHAROMYCES CEREVISIAE; TISSUE SPECIFICITY; U2OS CELL LINE; CHEMISTRY; GENE ONTOLOGY; GENETICS; METABOLISM; MISSENSE MUTATION; PRENYLATION; PROTEIN ANALYSIS; PROTEIN PROCESSING; PROTEOSTASIS DEFICIENCY; TUMOR CELL LINE; TWO HYBRID SYSTEM;

CELL LINE, TUMOR; GENE ONTOLOGY; HUMANS; LAMIN TYPE A; MUTATION, MISSENSE; PRENYLATION; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOSTASIS DEFICIENCIES; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 84899687973     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E14-02-0733     Document Type: Article

References (69)

1. Anderson DJ, Hetzer MW (2008). Reshaping of the endoplasmic reticulum limits the rate for nuclear envelope formation. J Cell Biol 182, 911-924.
2. Barrowman J, Hamblet C, George CM, Michaelis S (2008). Analysis of prelamin A biogenesis reveals the nucleus to be a CaaX processing compartment. Mol Biol Cell 19, 5398-5408.
3. Benedetti S et al. (2007). Phenotypic clustering of lamin A/C mutations in neuromuscular patients. Neurology 69, 1285-1292.
4. Bonaldo MF, Lennon G, Soares MB (1996). Normalization and subtraction: two approaches to facilitate gene discovery. Genome Res 6, 791-806.
5. Bonne G et al. (2000). Clinical and molecular genetic spectrum of autosomal dominant Emery-Dreifuss muscular dystrophy due to mutations of the lamin A/C gene. Ann Neurol 48, 170-180.
6. Bruston F, Delbarre E, Ostlund C, Worman HJ, Buendia B, Duband-Goulet I (2010). Loss of a DNA binding site within the tail of prelamin A contributes to altered heterochromatin anchorage by progerin. FEBS Lett 584, 2999-3004.
7. Capell BC, Erdos MR, Madigan JP, Fiordalisi JJ, Varga R, Conneely KN, Gordon LB, Der CJ, Cox AD, Collins FS (2005). Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing of Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci USA 102, 12879-12884.
8. Charloteaux B, Zhong Q, Dreze M, Cusick ME, Hill DE, Vidal M (2011). Protein-protein interactions and networks: forward and reverse edgetics. Methods Mol Biol 759, 197-213.
9. Corrigan DP, Kuszczak D, Rusinol AE, Thewke DP, Hrycyna CA, Michaelis S, Sinensky MS (2005). Prelamin A endoproteolytic processing in vitro by recombinant Zmpste24. Biochem J 387, 129-138.
10. Crisp M, Liu Q, Roux K, Rattner JB, Shanahan C, Burke B, Stahl PD, Hodzic D (2006). Coupling of the nucleus and cytoplasm: role of the LINC complex. J Cell Biol 172, 41-53.
11. Dahl KN, Scaffidi P, Islam MF, Yodh AG, Wilson KL, Misteli T (2006). Distinct structural and mechanical properties of the nuclear lamina in Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci USA 103, 10271-10276.
12. Dhe-Paganon S, Werner ED, Chi YI, Shoelson SE (2002). Structure of the globular tail of nuclear lamin. J Biol Chem 277, 17381-17384.
13. Dittmer TA, Misteli T (2011). The lamin protein family. Genome Biol 12, 222.
14. Dorner D, Gotzmann J, Foisner R (2007). Nucleoplasmic lamins and their interaction partners, LAP2alpha, Rb, and BAF, in transcriptional regulation. FEBS J 274, 1362-1373.
15. Dreze M, Monachello D, Lurin C, Cusick ME, Hill DE, Vidal M, Braun P (2010). High-quality binary interactome mapping. Methods Enzymol 470, 281-315.
16. Eriksson M et al. (2003). Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature 423, 293-298.
17. Fisher DZ, Chaudhary N, Blobel G (1986). cDNA sequencing of nuclear lamins A and C reveals primary and secondary structural homology to intermediate filament proteins. Proc Natl Acad Sci USA 83, 6450-6454.
18. Galiova G, Bartova E, Raska I, Krejci J, Kozubek S (2008). Chromatin changes induced by lamin A/C deficiency and the histone deacetylase inhibitor trichostatin A. Eur J Cell Biol 87, 291-303.
19. Garg A, Subramanyam L, Agarwal AK, Simha V, Levine B, D?Apice MR, Novelli G, Crow Y (2009). Atypical progeroid syndrome due to heterozygous missense LMNA mutations. J Clinic Endocrinol Metab 94, 4971-4983.
20. Glynn MW, Glover TW (2005). Incomplete processing of mutant lamin A in Hutchinson-Gilford progeria leads to nuclear abnormalities, which are reversed by farnesyltransferase inhibition. Hum Mol Genet 14, 2959-2969.
21. Goldman RD et al. (2004). Accumulation of mutant lamin A causes progressive changes in nuclear architecture in Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci USA 101, 8963-8968.
22. Gonzalez JM, Navarro-Puche A, Casar B, Crespo P, Andres V (2008). Fast regulation of AP-1 activity through interaction of lamin A/C, ERK1/2, and c-Fos at the nuclear envelope. J Cell Biol 183, 653-666.
23. Gonzalez JM, Pla D, Perez-Sala D, Andres V (2011). A-type lamins and Hutchinson-Gilford progeria syndrome: pathogenesis and therapy. Front Biosci 3, 1133-1146.
24. Gunteski-Hamblin AM, Song G, Walsh RA, Frenzke M, Boivin GP, Dorn GW 2nd, Kaetzel MA, Horseman ND, Dedman JR (1996). Annexin VI overexpression targeted to heart alters cardiomyocyte function in transgenic mice. Am J Physiol 270, H1091-1100.
25. Hozak P, Sasseville AM, Raymond Y, Cook PR (1995). Lamin proteins form an internal nucleoskeleton as well as a peripheral lamina in human cells. J Cell Sci 108, 635-644.
26. Huang da W, Sherman BT, Lempicki RA (2009). Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4, 44-57.
27. Ivorra C, Kubicek M, Gonzalez JM, Sanz-Gonzalez SM, Alvarez-Barrientos A, O?Connor JE, Burke B, Andres V (2006). A mechanism of AP-1 suppression through interaction of c-Fos with lamin A/C. Genes Dev 20, 307-320.
28. Jans SW, de Jong YF, Reutelingsperger CP, van der Vusse GJ, van Bilsen M (1998). Differential expression and localization of annexin V in cardiac myocytes during growth and hypertrophy. Mol Cell Biochem 178, 229-236.
29. Korfali N et al. (2012). The nuclear envelope proteome differs notably between tissues. Nucleus 3, 552-564.
30. Krimm I, Ostlund C, Gilquin B, Couprie J, Hossenlopp P, Mornon JP, Bonne G, Courvalin JC, Worman HJ, Zinn-Justin S (2002). The Ig-like structure of the C-terminal domain of lamin A/C, mutated in muscular dystrophies, cardiomyopathy, and partial lipodystrophy. Structure 10, 811-823.
31. Kubben N, Voncken JW, Demmers J, Calis C, van Almen G, Pinto Y, Misteli T (2010). Identification of differential protein interactors of lamin A and progerin. Nucleus 1, 513-525.
32. Kumaran RI, Muralikrishna B, Parnaik VK (2002). Lamin A/C speckles mediate spatial organization of splicing factor compartments and RNA polymerase II transcription. J Cell Biol 159, 783-793.
33. Lamesch P et al. (2007). hORFeome v3.1: a resource of human open reading frames representing over 10,000 human genes. Genomics 89, 307-315.
34. Lee DC, Welton KL, Smith ED, Kennedy BK (2009). A-type nuclear lamins act as transcriptional repressors when targeted to promoters. Exp Cell Res 315, 996-1007.
35. Liu B et al. (2005). Genomic instability in laminopathy-based premature aging. Nat Med 11, 780-785.
36. Macara IG (2001). Transport into and out of the nucleus. Microbiol Mol Biol Rev 65, 570-594.
37. Maier RH, Maier CJ, Onder K (2011). Construction of improved yeast two-hybrid libraries. Methods Mol Biol 729, 71-84.
38. Manju K, Muralikrishna B, Parnaik VK (2006). Expression of disease-causing lamin A mutants impairs the formation of DNA repair foci. J Cell Sci 119, 2704-2714.
39. Montes de Oca R, Shoemaker CJ, Gucek M, Cole RN, Wilson KL (2009). Barrier-to-autointegration factor proteome reveals chromatin-regulatory partners. PLoS One 4, e7050.
40. Muchir A, Bonne G, van der Kooi AJ, van Meegen M, Baas F, Bolhuis PA, de Visser M, Schwartz K (2000). Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B). Hum Mol Genet 9, 1453-1459.
41. Nikolova V et al. (2004). Defects in nuclear structure and function promote dilated cardiomyopathy in lamin A/C-deficient mice. J Clin Invest 113, 357-369.
42. Pegoraro G, Kubben N, Wickert U, Gohler H, Hoffmann K, Misteli T (2009). Ageing-related chromatin defects through loss of the NURD complex. Nat Cell Biol 11, 1261-1267.
43. Pendas AM et al. (2002). Defective prelamin A processing and muscular and adipocyte alterations in Zmpste24 metalloproteinase-deficient mice. Nat Genet 31, 94-99.
44. Raffaele Di Barletta M et al. (2000). Different mutations in the LMNA gene cause autosomal dominant and autosomal recessive Emery-Dreifuss muscular dystrophy. Am J Hum Genet 66, 1407-1412.
45. Rankin J, Ellard S (2006). The laminopathies: a clinical review. Clin Genet 70, 261-274.
46. Reichart B, Klafke R, Dreger C, Kruger E, Motsch I, Ewald A, Schafer J, Reichmann H, Muller CR, Dabauvalle MC (2004). Expression and localization of nuclear proteins in autosomal-dominant Emery-Dreifuss muscular dystrophy with LMNA R377H mutation. BMC Cell Biol 5, 12.
47. Rober RA, Weber K, Osborn M (1989). Differential timing of nuclear lamin A/C expression in the various organs of the mouse embryo and the young animal: a developmental study. Development 105, 365-378.
48. Saj M, Dabrowski R, Labib S, Jankowska A, Szperl M, Broda G, Szwed H, Tesson F, Bilinska ZT, Ploski R (2012). Variants of the lamin A/C (LMNA) gene in non-valvular atrial fibrillation patients: a possible pathogenic role of the Thr528Met mutation. Mol Diagn Ther 16, 99-107.
49. Savage DB et al. (2004). Familial partial lipodystrophy associated with compound heterozygosity for novel mutations in the LMNA gene. Diabetologia 47, 753-756.
50. Scharner J et al. (2011). Novel LMNA mutations in patients with Emery-Dreifuss muscular dystrophy and functional characterization of four LMNA mutations. Hum Mutat 32, 152-167.
51. Schirmer EC, Gerace L (2005). The nuclear membrane proteome: extending the envelope. Trends Biochem Sci 30, 551-558.
52. Sebillon P et al. (2003). Expanding the phenotype of LMNA mutations in dilated cardiomyopathy and functional consequences of these mutations. J Med Genet 40, 560-567.
53. Shumaker DK, Solimando L, Sengupta K, Shimi T, Adam SA, Grunwald A, Strelkov SV, Aebi U, Cardoso MC, Goldman RD (2008). The highly conserved nuclear lamin Ig-fold binds to PCNA: its role in DNA replication. J Cell Biol 181, 269-280.
54. Skrahina T, Piljic A, Schultz C (2008). Heterogeneity and timing of translocation and membrane-mediated assembly of different annexins. Exp Cell Res 314, 1039-1047.
55. Spann TP, Goldman AE, Wang C, Huang S, Goldman RD (2002). Alteration of nuclear lamin organization inhibits RNA polymerase II-dependent transcription. J Cell Biol 156, 603-608.
56. Stuurman N, Heins S, Aebi U (1998). Nuclear lamins: their structure, assembly, and interactions. J Struct Biol 122, 42-66.
57. Sullivan T, Escalante-Alcalde D, Bhatt H, Anver M, Bhat N, Nagashima K, Stewart CL, Burke B (1999). Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy. J Cell Biol 147, 913-920.
58. Suzuki Y, Kagawa N, Fujino T, Sumiya T, Andoh T, Ishikawa K, Kimura R, Kemmochi K, Ohta T, Tanaka S (2005). A novel high-throughput (HTP) cloning strategy for site-directed designed chimeragenesis and mutation using the Gateway cloning system. Nucleic Acids Res 33, e109.
59. Szeverenyi I et al. (2008). The Human Intermediate Filament Database: comprehensive information on a gene family involved in many human diseases. Hum Mutat 29, 351-360.
60. Taniura H, Glass C, Gerace L (1995). A chromatin binding site in the tail domain of nuclear lamins that interacts with core histones. J Cell Biol 131, 33-44.
61. Verstraeten VL et al. (2006). Compound heterozygosity for mutations in LMNA causes a progeria syndrome without prelamin A accumulation. Hum Mol Genet 15, 2509-2522.
62. Vytopil M et al. (2003). Mutation analysis of the lamin A/C gene (LMNA) among patients with different cardiomuscular phenotypes. J Med Genet 40, e132.
63. Weber K, Plessmann U, Traub P (1989). Maturation of nuclear lamin A involves a specific carboxy-terminal trimming, which removes the polyisoprenylation site from the precursor; implications for the structure of the nuclear lamina. FEBS Lett 257, 411-414.
64. Worman HJ, Bonne G (2007). ?Laminopathies?: a wide spectrum of human diseases. Exp Cell Res 313, 2121-2133.
65. Yamamoto Y, Yoshida A, Miyazaki N, Iwasaki K, Sakisaka T (2014). Arl6IP1 has the potency to shape the mammalian ER membrane in a reticulon-like fashion. Biochem J 458, 69-79.
66. Yang YS, Strittmatter SM (2007). The reticulons: a family of proteins with diverse functions. Genome Biol 8, 234.
67. Ye Q, Worman HJ (1995). Protein-protein interactions between human nuclear lamins expressed in yeast. Exp Cell Res 219, 292-298.
68. Yuan JH, Hu J, Zhao Z, Shen HR, Li N, Bing Q (2010). Mutation analysis of a Chinese family with autosomal dominant Emery-Dreifuss muscular dystrophy [in Chinese]. Chin J Med Genet 27, 136-139.
69. Zastrow MS, Vlcek S, Wilson KL (2004). Proteins that bind A-type lamins: integrating isolated clues. J Cell Sci 117, 979-987.